OSI Systems, Inc. Form 10-Q Summary
Business Context and Reporting Period
OSI Systems designs and manufactures specialized electronic systems and components and provides security screening services across Security, Healthcare, and Optoelectronics and Manufacturing. The filing covers the quarter and six months ended December 31, 2013, corresponding to the second quarter and first half of fiscal 2014. Results are unaudited and compared with the corresponding fiscal 2013 periods.
Key Financial Metrics
| Metric | Three Months Ended Dec. 31, 2013 | Six Months Ended Dec. 31, 2013 |
|---|---|---|
| Revenue | $236.4 million | $442.7 million |
| Gross profit | $80.9 million | $148.9 million |
| Gross margin | 34.2% | 33.6% |
| Operating income | $22.0 million | $32.5 million |
| Net income | $14.6 million | $21.0 million |
| Diluted EPS | $0.71 | $1.02 |
| Effective tax rate | 29.0% | 29.0% |
For the six months, operating cash flow was $75.0 million. Investing cash outflows were $54.3 million, including $41.7 million of capital expenditures and $10.1 million for acquisitions and other assets. Financing cash outflows were $16.5 million, including $12.1 million of share repurchases and $8.2 million of tax payments related to equity awards. Cash and cash equivalents were $39.9 million at December 31, 2013.
Total debt was $74.7 million, consisting primarily of $60.0 million outstanding under the revolving credit facility and $14.7 million of term and other long-term debt. Net debt was $34.8 million. The company had a $425.0 million revolving credit facility maturing in November 2016, with $115.6 million of letters of credit outstanding. Management stated that available funds, credit facilities, and operating cash flow should be sufficient for foreseeable operational needs.
Material Changes Versus the Prior Comparable Period
- Three-month revenue increased 22% from $194.0 million to $236.4 million; six-month revenue increased 18% from $375.7 million to $442.7 million.
- Three-month net income increased 17% from $12.4 million to $14.6 million; six-month net income increased 12% from $18.8 million to $21.0 million.
- Diluted EPS increased from $0.60 to $0.71 for the quarter and from $0.91 to $1.02 for the six-month period.
- Gross margin declined from 36.1% to 34.2% for the quarter and from 35.0% to 33.6% for the six months. The decline reflected faster growth in the lower-margin Optoelectronics and Manufacturing division and a greater mix of lower-margin contract manufacturing.
- Security revenue increased 16% for the quarter and 17% for the six months, driven primarily by Mexican turnkey screening services and cargo equipment sales. Six-month growth was partly offset by the prior-year contribution from London Olympic Games equipment.
- Healthcare revenue increased 12% for the quarter but only 1% for the six months, as patient monitoring growth was largely offset by lower anesthesia revenue from an older product line.
- Optoelectronics and Manufacturing revenue increased 33% for the quarter and 29% for the six months, supported by contract manufacturing and acquisitions. The division’s operating income declined to $2.1 million for the quarter and $6.9 million for the six months.
- Operating expenses increased 15% for the quarter and 13% for the six months. Six-month impairment, restructuring, and other charges increased to $6.4 million from $2.7 million.
- Operating cash flow increased $12.2 million year over year, while investing outflows fell substantially from $125.4 million to $54.3 million because of lower capital spending related to the Mexican turnkey program.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide specific quantitative revenue or earnings guidance. Management expressed confidence that liquidity will support foreseeable operational needs, but stated that the interim results are not necessarily indicative of full-year results.
- The TSA terminated for default a September 2013 delivery order after the Security division used an upgraded X-ray generator without obtaining required advance TSA approval. The matter was referred to the Department of Homeland Security, and the company could face restrictions or debarment from future U.S. federal government business.
- The company recorded $2.5 million of six-month charges related to TSA contract issues, including product removal, storage, refurbishing, legal, and other costs.
- A putative securities class action filed in December 2013 alleges misrepresentations concerning Advanced Imaging Technology testing, product privacy concerns, and TSA contract compliance. The company believes the claims lack merit, but stated that the outcome and potential loss cannot presently be estimated.
- Contingent acquisition payments could reach a maximum of $51.0 million; $20.8 million was recorded in other long-term liabilities at December 31, 2013.
- An advance from the Mexican government for a turnkey screening project had $87.5 million outstanding and is subject to a company guarantee until amortized.
- The company disclosed soil and groundwater contamination at its Hawthorne, California facility. Further studies were planned, but no liability was accrued because any loss was not considered probable and reasonably estimable.
- Restructuring and facility consolidation activities continued in the Healthcare and Optoelectronics and Manufacturing divisions. The company also incurred employee termination costs and professional fees.
- Key ongoing risks include U.S. government budget and sequestration uncertainty, dependence on government contracts, healthcare capital-spending weakness, international and foreign-currency exposure, customer acceptance and warranty estimates, and variable-rate debt.
Important Facts for Investors to Verify
- Progress and financial impact of the TSA review, delivery-order termination, contract disputes, and any potential debarment or enforcement actions.
- Status, expected costs, and potential damages associated with the securities class action and other legal proceedings.
- Execution and profitability of the Mexican turnkey screening program, including the $87.5 million customer advance and related capital requirements.
- Whether lower gross margins in Optoelectronics and Manufacturing persist as contract manufacturing becomes a larger portion of revenue.
- Healthcare demand trends and the timing of adoption of the new anesthesia system.
- Future capital expenditures, acquisition spending, contingent consideration, and availability under the revolving credit facility after letters of credit.
- Potential environmental remediation obligations at the Hawthorne facility, which were not accrued in the filing.